Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Fortified Oral Rehydration Therapy

Phase 2Small molecule

PPaul A Breslin

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q2 2027

Phase 1/2Recruiting

Diarrhea

NCT06137014

Clinical

Trials by Indication[1]

Diarrhea1 trial

Fortified Oral Rehydration Therapy for Pediatric Diarrhea

Recruiting·PPaul A Breslin·Phase 1/2·NCT06137014·72 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Fortified Oral Rehydration Therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Fortified Oral Rehydration Therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Fortified Oral Rehydration Therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Paul A Breslin company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: PPaul A Breslin

Related News